M.G. Chambers

3.7k citations

46 papers · 2.6k indexed · 1 hit paper · h-index 21

Rheumatology top 0.5%
- Osteoarthritis Treatment and Mechanisms 22
Pharmacology top 1%
- Inflammatory mediators and NSAID effects 22
- Cannabis and Cannabinoid Research 4
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 9
Equine top 2%
Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
Surgery
- Knee injuries and reconstruction techniques 3
Molecular Biology
- Sphingolipid Metabolism and Signaling 3
- Chemical Synthesis and Analysis 3

Co-authors: W. B. Van Den Berg Christopher B. Little S.S. Glasson Roger M. Mason Michael T. Bayliss J.L. Oskins Kristen M. Clements Chaohua Lin
Cited by: Rheumatology Pharmacology Immunology and Allergy
Journals: Osteoarthritis and Cartilage (16 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (4 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

M.G. Chambers

45 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by M.G. Chambers

Since Specialization

Citations

This map shows the geographic impact of M.G. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Chambers more than expected).

Fields of papers citing papers by M.G. Chambers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Chambers. The network helps show where M.G. Chambers may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M.G. Chambers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M.G. Chambers Line = papers co-authored together M.G. Chambers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A multi-model approach identifies ALW-II-41-27 as a promising therapy for osteoarthritis-associated inflammation and endochondral ossification Heliyon ·Z. Y. Zhang,R Lesage,Nicole Kops,Niamh Fahy,云善柳,Cindy W. Leung,Y.M. Bastiaansen-Jenniskens,Liesbet Geris,M.G. Chambers,Andrew A. Pitsillides,Roberto Narcisi,Gerjo J.V.M. van Osch	2024	1
2	Analgesic and anti‐inflammatory properties of novel, selective, and potent EP4 receptor antagonists Pharmacology Research & Perspectives ·Srinivasan Chandrasekhar,Jonathan Berry,Anita K. Harvey,J.L. Oskins,Chaohua Lin,Xushan Wang,María‐Jesús Blanco,Matthew J. Fisher,Andrew Ellefson,Donsuk Lee,Tatiana Vetman,Alan M. Warshawsky,William “Brit” Kirwan,Alison M. Bendele,M.G. Chambers	2017	15
3	Sustained efficacy of intra-articular SB-061, a novel bioconjugate inspired by aggrecan, in a rat model of osteoarthritis Osteoarthritis and Cartilage ·Kate Stuart,Sergio Luiz Gargioni,M.A. Benitez,Carla Rodrigues Zanin,Alan Chan,Fathima Farsana O K,J.L. Oskins,Chien‐Yuan Lin,M.A. Karsdal,M.G. Chambers,John Paderi	2017	2
4	Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain Osteoarthritis and Cartilage ·Jason J. McDougall,M.E. de Ruiz Holgado,Niklas Schuelert,David Francischelli,Chaohua Lin,J.L. Oskins,Hong‐Thuy Bui,M.G. Chambers	2016	54
5	Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia Journal of Pharmacology and Experimental Therapeutics ·S. Chandrasekhar,Anita K. Harvey,Xiuping Yu,M.G. Chambers,J.L. Oskins,Chaohua Lin,Thomas Seng,Stefan Jon Thibodeaux,Bryan H. Norman,Andrzej Jaśkiewicz,Donsuk Lee,M. J. Fisher	2016	20
6	Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists Bioorganic & Medicinal Chemistry Letters ·María‐Jesús Blanco,Tatiana Vetman,Srinivasan Chandrasekhar,Matthew J. Fisher,Anita K. Harvey,Andrew Ellefson,M.G. Chambers,Chaohua Lin,Daniel R. Mudra,J.L. Oskins,Xu-Shan Wang,Xiaopeng Yu,Alan M. Warshawsky	2016	10
7	Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain Osteoarthritis and Cartilage ·Robert J. Benschop,Emily C. Collins,Ryan J. Darling,Barrett W. Allan,Donmienne Leung,Elaine M. Conner,Bosen Min,Brady Gaynor,Evtjuchin Ap,López Betty,Hae Dong Koo,Deborah A. Ozga,Deborah R. McCarty,J.L. Oskins,Chaohua Lin,Kirk W. Johnson,M.G. Chambers	2014	100
8	Selective RAR gamma antagonist LY2813631 protects against retinoid induced cartilage degradation in preclinical models of arthritis Osteoarthritis and Cartilage ·Bryan H. Norman,Andrew G. Geiser,M.G. Chambers,T L Moore,S. Chandrasekhar,Todd J. Page,Thomas J. Bleisch,Peter G. Mitchell	2013	1
9	Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritis Bioorganic & Medicinal Chemistry Letters ·Funda Kartoz,Athip Boonsiriwit,Grégory Bar,弘子杉森,Paul Edwards,Reginald Brys,M.G. Chambers,Wolfgang Schmidt,Angus M. MacLeod,Emilly Marinho Martins,静男古謝,Véronique Birault,Joelle Le,S. K. Goyal,María Alejandra Ardila Rosas,Kevin M. Nash,Nicholas Haltmeyer	2012	12
10	A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs Osteoarthritis and Cartilage ·Craig Swearingen,M.G. Chambers,Chaohua Lin,Han Ru-bing,Christopher J. Rito,Gözde GÜLKANAT,Joe E. Dotzlaf,Jesús BECERRA C.,S. Chandrasekhar,Kevin L. Duffin,Peter G. Mitchell,Timothy B. Durham,Michael R. Wiley,Kannan Thirunavukkarasu	2010	21
11	The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mousebreakdown → Osteoarthritis and Cartilage ·S.S. Glasson,M.G. Chambers,W. B. Van Den Berg,Christopher B. Little	2010	1292
12	Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis Pain ·Niklas Schuelert,Michael P. Johnson,J.L. Oskins,郑桂元,M.G. Chambers,Jason J. McDougall	2010	65
13	The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line Osteoarthritis and Cartilage ·C. K.,M.G. Chambers,Roger M. Mason	2006	25
14	Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation Analytical Biochemistry ·Michael J. Berna,B.I. Halperin,Kevin L. Duffin,Peter G. Mitchell,M.G. Chambers,Brad Ackermann	2006	42
15	Distribution of Endo180 receptor and ligand in developing articular cartilage Osteoarthritis and Cartilage ·Michael J. Howard,M.G. Chambers,Roger M. Mason,Clare M. Isacke	2003	22
16	Chondrocyte death during murine osteoarthritis Osteoarthritis and Cartilage ·C. K.,Dalit Ash Any,M.G. Chambers,M. V. Kayser,Roger M. Mason	2003	76
17	Gene deletion of either interleukin‐1β, interleukin‐1β–converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy Arthritis & Rheumatism ·Kristen M. Clements,Borsah Tanueh,M.G. Chambers,Denise M. Visco,A. Robin Poole,Roger M. Mason	2003	173
18	Comparison of collagenase-cleaved articular cartilage collagen in mice in the naturally occurring STR/ort model of osteoarthritis and in collagen-induced arthritis Osteoarthritis and Cartilage ·Borsah Tanueh,M.G. Chambers,A. Robin Poole,Armel Fradin,Roger M. Mason	2002	20
19	Expression of collagen and aggrecan genes in normal and osteoarthritic murine knee joints Osteoarthritis and Cartilage ·M.G. Chambers,Támara Kuffner,A. Soria,Kathryn S.E. Cheah,Roger M. Mason	2002	45
20	Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis Osteoarthritis and Cartilage ·J. Flannelly,M.G. Chambers,Jayesh Dudhia,Rosalind M. Hembry,Gillian Murphy,Roger M. Mason,Michael T. Bayliss	2002	64

About M.G. Chambers

M.G. Chambers is a scholar working on Pharmacology, Rheumatology, Immunology and Allergy, Toxicology and Anatomy, having authored 46 papers that have together received 2.6k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (22 papers), Inflammatory mediators and NSAID effects (22 papers), Cell Adhesion Molecules Research (9 papers), Protease and Inhibitor Mechanisms (4 papers), Cannabis and Cannabinoid Research (4 papers), Knee injuries and reconstruction techniques (3 papers), Sphingolipid Metabolism and Signaling (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Rheumatology (1.8k citations), Pharmacology (749 citations), Immunology and Allergy (218 citations), Equine (50 citations) and Cancer Research (450 citations). M.G. Chambers has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include W. B. Van Den Berg, Christopher B. Little, S.S. Glasson, Roger M. Mason, Michael T. Bayliss, J.L. Oskins, Kristen M. Clements, Chaohua Lin, A. Robin Poole and Denise M. Visco. Their work appears in journals such as Osteoarthritis and Cartilage, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Inflammation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact